We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$6.8B
AUM Growth
+$947M
Cap. Flow
+$838M
Cap. Flow %
12.32%
Top 10 Hldgs %
21.42%
Holding
2,018
New
252
Increased
1,012
Reduced
601
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 4.99%
2 Financials 4.82%
3 Healthcare 4.39%
4 Industrials 4.19%
5 Consumer Staples 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDCC icon
1701
InterDigital
IDCC
$8.99B
$216K ﹤0.01%
2,796
+15
+0.5% +$1.26K
JNPR
1702
DELISTED
Juniper Networks
JNPR
$216K ﹤0.01%
7,736
-2,149
-22% -$62.5K
MCN
1703
Madison Covered Call & Equity Strategy Fund
MCN
$119M
$216K ﹤0.01%
27,563
+700
+3% +$5.58K
PBJ icon
1704
Invesco Food & Beverage ETF
PBJ
$106M
$216K ﹤0.01%
6,865
ST icon
1705
Sensata Technologies
ST
$6.66B
$216K ﹤0.01%
+5,052
New +$208K
VALE icon
1706
Vale
VALE
$63.4B
$216K ﹤0.01%
+24,738
New +$210K
CIM
1707
Chimera Investment
CIM
$980M
$215K ﹤0.01%
+3,840
New +$222K
EVN
1708
Eaton Vance Municipal Income Trust
EVN
$429M
$215K ﹤0.01%
16,571
HYT icon
1709
BlackRock Corporate High Yield Fund
HYT
$1.37B
$215K ﹤0.01%
19,631
-9,309
-32% -$103K
FCFP
1710
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$215K ﹤0.01%
16,662
ERH
1711
Allspring Utilities & High Income Fund
ERH
$103M
$214K ﹤0.01%
+16,523
New +$217K
MED icon
1712
Medifast
MED
$135M
$214K ﹤0.01%
5,172
-1
-0% -$43
BMRN icon
1713
BioMarin Pharmaceuticals
BMRN
$13.3B
$213K ﹤0.01%
+2,345
New +$213K
HOLX
1714
DELISTED
Hologic
HOLX
$213K ﹤0.01%
+4,700
New +$207K
IHE icon
1715
iShares US Pharmaceuticals ETF
IHE
$1.66B
$213K ﹤0.01%
4,122
-582
-12% -$29.4K
GWPH
1716
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$213K ﹤0.01%
+2,120
New +$228K
EIM
1717
Eaton Vance Municipal Bond Fund
EIM
$499M
$212K ﹤0.01%
16,691
+51
+0.3% +$645
FTF
1718
Franklin Limited Duration Income Trust
FTF
$234M
$212K ﹤0.01%
17,934
-1,905
-10% -$22.8K
EEQ
1719
DELISTED
Enbridge Energy Management Llc
EEQ
$212K ﹤0.01%
15,852
-5,929
-27% -$86.1K
UHS icon
1720
Universal Health Services
UHS
$10.5B
$211K ﹤0.01%
+1,732
New +$206K
AJG icon
1721
Arthur J. Gallagher & Co
AJG
$64.7B
$210K ﹤0.01%
3,674
-136
-4% -$7.69K
BGR icon
1722
BlackRock Energy and Resources Trust
BGR
$422M
$210K ﹤0.01%
16,156
+723
+5% +$9.71K
FRA icon
1723
BlackRock Floating Rate Income Strategies Fund
FRA
$388M
$210K ﹤0.01%
14,923
-5,700
-28% -$81.5K
IGF icon
1724
iShares Global Infrastructure ETF
IGF
$10.6B
$210K ﹤0.01%
+4,778
New +$209K
MLAB icon
1725
Mesa Laboratories
MLAB
$569M
$210K ﹤0.01%
1,465
-194
-12% -$27.6K

Similar funds

Cambridge Investment Research Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Cambridge Investment Research Advisors held 2,018 positions worth $6.8B, up 16% from $5.85B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $838M of net new capital in Q2 2017, opening 252 new positions and adding to 1,012 existing holdings. Its largest new stake was Apple: 3,555,600 shares worth $128M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Financials ETF, an estimated $9.78M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2017 buy was Apple: 3,555,600 shares worth $128M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $24M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2017 reduction was iShares US Financials ETF, cutting an estimated $9.78M.
  • Cambridge Investment Research Advisors fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $3.81M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $6.8B portfolio in Q2 2017.
  • Cambridge Investment Research Advisors opened 252 new positions and closed 90 in Q2 2017.
  • Cambridge Investment Research Advisors's portfolio value rose 16% quarter-over-quarter to $6.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2017, filed 8 Aug 2017.